inPractice® - Tipranavir

Agents Used in Antiretroviral Therapy

Authors: Philip Grant, MD (More Info)
Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
Last Reviewed: 7/19/21 (What's New)

Summary

Tipranavir boosted with ritonavir is indicated for combination treatment of HIV-infected patients who are treatment experienced and infected with HIV strains resistant to more than 1 PI^{[FDA Tipranavir]}
Dosing is tipranavir 500 mg with ritonavir 200 mg twice daily
Tipranavir/ritonavir should not be coadministered with etravirine or other PIs^{[FDA Tipranavir]}

Action required

Login now to access all of your entitled content
or
View additional options to gain access to this content

Keywords: Hepatic Complications, Initial Antiretroviral Therapy, Management of Treatment-Experienced Patients, Special Populations, Treatment Complications